- Report
- October 2024
- 199 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 231 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- January 2022
- 112 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- June 2021
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Photopheresis is a type of surgical device used to treat a variety of conditions, including graft-versus-host disease, cutaneous T-cell lymphoma, and systemic sclerosis. It is a process in which a patient's blood is removed, exposed to ultraviolet light, and then returned to the patient. The ultraviolet light activates a drug, which is then released into the bloodstream. This drug helps to reduce inflammation and improve the patient's immune system.
Photopheresis is a relatively new technology, but it has been gaining traction in the surgical device market. It is a safe and effective treatment option for many conditions, and it is becoming increasingly popular among medical professionals. Photopheresis is also being used in combination with other treatments, such as chemotherapy and immunotherapy, to improve patient outcomes.
Some companies in the Photopheresis product market include Apheresis Technologies, Inc., Fresenius Medical Care, and Terumo BCT. Show Less Read more